About MDxHealth SA

Company Description

Mdxhealth is a commercial-stage precision diagnostics company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of prostate cancer and other urologic diseases. The Company’s tests are based on proprietary genetic, epigenetic and other complex molecular technologies.

Mdxhealth is dedicated to providing highly accurate and clinically actionable urologic solutions to inform patient diagnosis and treatment while improving healthcare economics for payers and providers.

Year founded

2003

Served area

Worldwide

Headquarters

CAP Business Center Rue d'Abhooz 31, 4040 Herstal, Liège – Belgium

Shareholder information

Shares outstanding

162,880,936

IPO

June 26, 2006

Stock exchange(s)

Euronext Brussels

Contact

Newsletter

Subscribe to our newsletter and receive information about recent IPOs, news in the European capital market and more.